Jenny Gumperz
University of Wisconsin School of Medicine and Public Health, WI, United States
- This delegate is presenting an abstract at this event.
Dr. Gumperz' research focuses on understanding the molecular recognition strategies and immunological functions of human innate lymphocytes such as NKT cells, with the ultimate goal of developing immunotherapeutic approaches utilizing these aspects of innate immunity. A major current direction of her lab involves using "humanized" mice (i.e. mice engrafted with human immune cells) to model the functions and interactions of human immune cells that lead to physiological outcomes in cancer, inflammation, and infectious diseases.
Presentations this author is a contributor to:
Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells (#65)
2:05 PM
Masaki Terabe
Therapy of Cancer and Other Diseases 2
Metabolic profile of human iNKT cells supports antitumor function in nutrient-deprived tumor environments (#153)
12:30 PM
Nikhila S Bharadwaj
Lunch & Poster Session 2
Anti-tumor adjuvancy by human CD4+ iNKT cells (#57)
9:40 AM
Jenny Gumperz
Therapy of Cancer and Other Diseases 1
CD1-MR1 2025